Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of Seroquel SR for major depressive disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Seroquel SR (quetiapine extended-release)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-04-01